rxstat › Shortages › Deferoxamine

Deferoxamine shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Deferoxamine has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 3
Reports on file
18

Reports by product

Resolved
DEFEROXAMINE MESYLATE FOR INJECTION
500MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02241600 · ended Mar 24, 2025 · Disruption of the manufacture of the drug.
Resolved
DEFEROXAMINE MESYLATE FOR INJECTION
2G · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02247022 · ended Mar 11, 2025 · Disruption of the manufacture of the drug.
Resolved
DESFERAL 500MG
500MG · POWDER FOR SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 01981242 · ended Jan 6, 2025 · Demand increase for the drug.
Resolved
DEFEROXAMINE MESYLATE FOR INJECTION
2G · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02247022 · ended Oct 23, 2024 · Disruption of the manufacture of the drug.
Resolved
DEFEROXAMINE MESYLATE FOR INJECTION
500MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02241600 · ended Oct 22, 2024 · Disruption of the manufacture of the drug.
Resolved
DESFERAL 500MG
500MG · POWDER FOR SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 01981242 · ended Sep 5, 2024 · Demand increase for the drug.
Resolved
DESFERAL 500MG
500MG · POWDER FOR SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 01981242 · ended Jun 17, 2024 · Demand increase for the drug.
Resolved
DEFEROXAMINE MESYLATE FOR INJECTION
500MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02241600 · ended Apr 24, 2024 · Disruption of the manufacture of the drug.
Resolved
DEFEROXAMINE MESYLATE FOR INJECTION
2G · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02247022 · ended Apr 17, 2024 · Disruption of the manufacture of the drug.
Resolved
DESFERAL 500MG
500MG · POWDER FOR SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 01981242 · ended Sep 29, 2023 · Demand increase for the drug.
Resolved
DEFEROXAMINE MESYLATE FOR INJECTION
500MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02241600 · ended Aug 18, 2023 · Disruption of the manufacture of the drug.
Avoided
DEFEROXAMINE MESYLATE FOR INJECTION
2G · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02247022 · ended Dec 5, 2022 · Disruption of the manufacture of the drug.

Showing 12 of 18 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Deferoxamine. Health Canada has 18 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Deferoxamine is classified under “ALL OTHER THERAPEUTIC PRODUCTS” (ATC V03AC).

Recent changes

Common questions

When will Deferoxamine be back in stock in Canada?

Deferoxamine has no active shortage; supply is normal per Health Canada reports.

Why is Deferoxamine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (all other therapeutic products)

Widespread shortageMesna3 of 3 reported products affected · est. return Aug 31, 2026Widespread shortagePolystyrene Sulfonate3 of 6 reported products affected · est. return Oct 9, 2026Partial shortageDeferasirox1 of 21 reported products affectedPartial shortageDexrazoxane1 of 3 reported products affectedPartial shortageLeucovorin1 of 6 reported products affected · est. return Jul 24, 2026Partial shortageMethylene Blue1 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.